Researchers have been looking for ways to administer the drug orally, and researchers at Carnegie Mellon University have now shown such a feat is possible
Patients with Type 2 diabetes who were treated with the newer generation of insulin analog drugs did not have substantially better outcomes than those treated with less costly human insulin